Translocations, fusion genes, and acute leukemia
暂无分享,去创建一个
[1] T. Hoshino,et al. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[2] A. Look,et al. The Chimeric E2A-HLF Transcription Factor Abrogates p53-Induced Apoptosis in Myeloid Leukemia Cells , 1998 .
[3] M. Cleary,et al. Growth stimulation of primary B cell precursors by the anti-phosphatase Sbf1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[4] G. Stein,et al. Interrelationships of nuclear structure and transcriptional control: Functional consequences of being in the right place at the right time , 1998, Journal of cellular biochemistry.
[5] N. Heerema,et al. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. , 1998, Blood.
[6] K. Howe,et al. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. , 1998, American journal of human genetics.
[7] A. Dejean,et al. Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[8] F. Barr. Translocations, cancer and the puzzle of specificity , 1998, Nature Genetics.
[9] M. Whiteley,et al. The Drosophila Polycomb group gene pleiohomeotic encodes a DNA binding protein with homology to the transcription factor YY1. , 1998, Molecular cell.
[10] M. Ohki,et al. Interaction and functional cooperation of the leukemia‐associated factors AML1 and p300 in myeloid cell differentiation , 1998, The EMBO journal.
[11] J. Downing,et al. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. , 1998, Blood.
[12] C. Croce,et al. Identification and characterization of the ARP1 gene, a target for the human acute leukemia ALL1 gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Cleary,et al. Association of SET domain and myotubularin-related proteins modulates growth control , 1998, Nature Medicine.
[14] J. Mills,et al. Activation of a PP2A-like phosphatase and dephosphorylation of tau protein characterize onset of the execution phase of apoptosis. , 1998, Journal of cell science.
[15] S. Ogawa,et al. The AML1/ETO(MTG8) and AML1/Evi-1 Leukemia-Associated Chimeric Oncoproteins Accumulate PEBP2β(CBFβ) in the Nucleus More Efficiently Than Wild-Type AML1 , 1998 .
[16] S. Minucci,et al. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia , 1998, Nature.
[17] S. Inoue,et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia , 1998, Nature.
[18] G. Sauvageau,et al. Stage-specific expression of polycomb group genes in human bone marrow cells. , 1998, Blood.
[19] Tony Kouzarides,et al. Retinoblastoma protein recruits histone deacetylase to repress transcription , 1998, Nature.
[20] P. Sorensen,et al. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma , 1998, Nature Genetics.
[21] S. Antonarakis,et al. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Greaves,et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[23] U. Thorsteinsdóttir,et al. Hox homeobox genes as regulators of normal and leukemic hematopoiesis. , 1997, Hematology/oncology clinics of North America.
[24] A T Look,et al. Oncogenic transcription factors in the human acute leukemias. , 1997, Science.
[25] G. Walter,et al. HRX Leukemic Fusion Proteins Form a Heterocomplex with the Leukemia-associated Protein SET and Protein Phosphatase 2A* , 1997, The Journal of Biological Chemistry.
[26] M. Grunstein. Histone acetylation in chromatin structure and transcription , 1997, Nature.
[27] S. Korsmeyer,et al. Defects in yolk sac hematopoiesis in Mll-null embryos. , 1997, Blood.
[28] A. Dejean,et al. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor α (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia , 1997 .
[29] R. Evans,et al. Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 , 1997, Cell.
[30] A. Gould. Functions of mammalian Polycomb group and trithorax group related genes. , 1997, Current opinion in genetics & development.
[31] J. Licht,et al. Transcription factors, normal myeloid development, and leukemia. , 1997, Blood.
[32] T. Golub,et al. Yolk sac angiogenic defect and intra‐embryonic apoptosis in mice lacking the Ets‐related factor TEL , 1997, The EMBO journal.
[33] J. Dick,et al. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.
[34] L. Hu,et al. The role of mel-18, a mammalian Polycomb group gene, during IL-7-dependent proliferation of lymphocyte precursors. , 1997, Immunity.
[35] M. Cleary,et al. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures. , 1997, Blood.
[36] M. Yaniv,et al. Components of the Human SWI/SNF Complex Are Enriched in Active Chromatin and Are Associated with the Nuclear Matrix , 1997, The Journal of cell biology.
[37] J. Rowley,et al. Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Aurrand-Lions,et al. Altered cellular proliferation and mesoderm patterning in Polycomb-M33-deficient mice. , 1997, Development.
[39] S. Korsmeyer,et al. HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint , 1997, Nature.
[40] C. Wijmenga,et al. Failure of Embryonic Hematopoiesis andLethal Hemorrhages in Mouse Embryos Heterozygousfor a Knocked-In Leukemia Gene CBFB–MYH11 , 1996, Cell.
[41] F. Alt,et al. The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo , 1996, Cell.
[42] F. Alt,et al. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. , 1996, Cell.
[43] R. Krumlauf,et al. Retinoids and Hox genes , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] T. Rabbitts,et al. An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion Oncogenes , 1996, Cell.
[45] S. Orkin,et al. The transcriptional control of hematopoiesis. , 1996, Blood.
[46] Q. Lu,et al. Structural determinants within Pbx1 that mediate cooperative DNA binding with pentapeptide-containing Hox proteins: proposal for a model of a Pbx1-Hox-DNA complex , 1996, Molecular and cellular biology.
[47] J. Downing,et al. AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.
[48] S. Korsmeyer,et al. Altered Hox expression and segmental identity in Mll-mutant mice , 1995, Nature.
[49] G. Huez,et al. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. , 1995, Blood.
[50] P. Harte,et al. The Drosophila trithorax proteins contain a novel variant of the nuclear receptor type DNA binding domain and an ancient conserved motif found in other chromosomal proteins , 1995, Mechanisms of Development.
[51] I. Takenaka,et al. Regulation of the Sequence-specific DNA Binding Function of p53 by Protein Kinase C and Protein Phosphatases (*) , 1995, The Journal of Biological Chemistry.
[52] T. Rabbitts,et al. Chromosomal translocations in human cancer , 1994, Nature.
[53] G. Reuter,et al. The protein encoded by the Drosophila position‐effect variegation suppressor gene Su(var)3‐9 combines domains of antagonistic regulators of homeotic gene complexes. , 1994, The EMBO journal.
[54] M. Sofroniew,et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. , 1994, Genes & development.
[55] Myriam Alcalay,et al. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells , 1993, Cell.
[56] T. Rabbitts,et al. TRANSCRIPTION FACTORS AND CHROMOSOMAL TRANSLOCATIONS IN LEUKEMIA , 1993 .
[57] M. Oken,et al. Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. , 1987, The New England journal of medicine.
[58] C. Haworth,et al. Leukaemia , 1982, British Journal of Cancer.
[59] A. Look,et al. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells. , 1998, Blood.
[60] T. Jenuwein,et al. SET domain proteins modulate chromatin domains in eu- and heterochromatin , 1998, Cellular and Molecular Life Sciences CMLS.
[61] K. Tanaka,et al. The AML1/ETO(MTG8) and AML1/Evi-1 leukemia-associated chimeric oncoproteins accumulate PEBP2beta(CBFbeta) in the nucleus more efficiently than wild-type AML1. , 1998, Blood.
[62] T. Golub,et al. The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms. , 1997, Current topics in microbiology and immunology.
[63] T. Lufkin. Transcriptional regulation of vertebrate Hox genes during embryogenesis. , 1997, Critical reviews in eukaryotic gene expression.
[64] R. Krumlauf,et al. Paralogous Hox genes: function and regulation. , 1996, Annual review of genetics.
[65] V. Saha,et al. Chromosome abnormalities in leukaemia: the 11q23 paradigm. , 1996, Cancer surveys.
[66] J. Simon,et al. Locking in stable states of gene expression: transcriptional control during Drosophila development. , 1995, Current opinion in cell biology.